[Clinical study of the secondary effects associated with taking a triphasic anti-ovulatory contraceptive].
D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D009644:Norgestrel / Q000009:adverse effects*; D011446:Prospective Studies; D014592:Uterine Hemorrhage / Q000139:chemically induced
D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D003280:Contraceptives, Oral, Synthetic; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination
Etude clinique des effets secondaires liés à la prise d'un complexe antiovulatoire triphasique.